Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.
Francis
C W
CW
Department of Medicine, University of Rochester School of Medicine & Dentistry, New York 14642.
Kornberg
A
A
D000818:Animals; D015415:Biomarkers / Q000097:blood; D016903:Drug Monitoring / Q000379:methods*; D005337:Fibrin / Q000032:analysis; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy*
D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D005337:Fibrin; D005341:Fibrinolysin